American Journal of Psychiatry
- Volume 179
- Number 10
- October 2022
Editor’s Note
Editorials
Reviews and Overviews
Articles
Publication date: 15 June 2022
Pages715–725Objective: The diagnostic criteria for opioid use disorder, originally developed for heroin, did not anticipate the surge in prescription opioid use and the resulting complexities in diagnosing prescription opioid use disorder (POUD), including ...
https://doi.org/10.1176/appi.ajp.21070721Publication date: 15 June 2022
Pages726–739Objective: Extensive exposure to prescription-type opioids has resulted in major harm worldwide, calling for better-adapted approaches to opioid agonist therapy. The authors aimed to determine whether flexible take-home buprenorphine/naloxone is as ...
https://doi.org/10.1176/appi.ajp.21090964Publication date: 28 July 2022
Pages740–747Objective: The authors examined the impact of COVID-19-related policies reducing barriers to telehealth delivery of buprenorphine treatment for opioid use disorder (OUD) on buprenorphine treatment across different modalities (telephone, video, and in-...
https://doi.org/10.1176/appi.ajp.21111141Publication date: 28 July 2022
Pages748–757Objective: In the United States, adult cannabis use has increased over time, but less information is available on time trends in cannabis use disorder. The authors used Veterans Health Administration (VHA) data to examine change over time in cannabis use ...
https://doi.org/10.1176/appi.ajp.22010034Publication date: 28 July 2022
Pages758–767Objective: Mindfulness-based interventions are widely used to target pain, yet their neural mechanisms of action are insufficiently understood. The authors studied neural and subjective pain response in a randomized active-control trial of mindfulness-...
https://doi.org/10.1176/appi.ajp.21020145APA Official Actions
Correction
Past Issues
View Issues Archive
Vol. 181 | No. 12
Vol. 181 | No. 11
Vol. 181 | No. 10
